These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinicopathologic features of pityriasis rosea-like drug eruption secondary to imatinib: A case report and review of the literature. Durgin JS; Whittington CP; Harrell J; Mervak JE; Smith EH J Cutan Pathol; 2024 Nov; 51(11):860-865. PubMed ID: 39021288 [TBL] [Abstract][Full Text] [Related]
7. Pityriasis rosea-like drug eruption due to nortriptyline in a patient with vulvodynia. Bangash HK; Finch T; Petronic-Rosic V; Sethi A; Abramsohn E; Lindau ST J Low Genit Tract Dis; 2013 Apr; 17(2):226-9. PubMed ID: 23343697 [TBL] [Abstract][Full Text] [Related]
8. Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases. Brazzelli V; Prestinari F; Roveda E; Barbagallo T; Bellani E; Vassallo C; Orlandi E; Passamonti F; Borroni G J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S240-3. PubMed ID: 16227099 [TBL] [Abstract][Full Text] [Related]
9. Pityriasis Rosea: Diagnosis and Treatment. Villalon-Gomez JM Am Fam Physician; 2018 Jan; 97(1):38-44. PubMed ID: 29365241 [TBL] [Abstract][Full Text] [Related]
10. Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center. Atzori L; Pinna AL; Ferreli C; Aste N Dermatol Online J; 2006 Jan; 12(1):1. PubMed ID: 16638369 [TBL] [Abstract][Full Text] [Related]
12. Pityriasis rosea-like drug eruption due to bupropion: a case report. Polat M; Uzun Ö; Örs I; Boran Ç Hum Exp Toxicol; 2014 Dec; 33(12):1294-6. PubMed ID: 24700110 [TBL] [Abstract][Full Text] [Related]
15. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine. Valk B; Bender B Cutis; 2021 Dec; 108(6):317-318. PubMed ID: 35167784 [TBL] [Abstract][Full Text] [Related]
16. Ondansetron for Treatment of Nausea and Vomiting of Pregnancy and the Risk of Specific Birth Defects. Parker SE; Van Bennekom C; Anderka M; Mitchell AA; Obstet Gynecol; 2018 Aug; 132(2):385-394. PubMed ID: 29995744 [TBL] [Abstract][Full Text] [Related]
17. Recurrent pityriasis rosea: A case report. Li A; Li P; Li Y; Li W Hum Vaccin Immunother; 2018 Apr; 14(4):1024-1026. PubMed ID: 29182459 [TBL] [Abstract][Full Text] [Related]
18. Pityriasis rosea-like eruption due to pneumococcal vaccine in a child with nephrotic syndrome. Sasmaz S; Karabiber H; Boran C; Garipardic M; Balat A J Dermatol; 2003 Mar; 30(3):245-7. PubMed ID: 12692364 [TBL] [Abstract][Full Text] [Related]
19. Segmental lesions in pityriasis rosea: a rare presentation. Zawar V; Godse K Skinmed; 2011; 9(6):382-4. PubMed ID: 22256628 [TBL] [Abstract][Full Text] [Related]
20. Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report. Birlutiu V; Birlutiu RM; Iancu GM Medicine (Baltimore); 2021 Apr; 100(14):e25352. PubMed ID: 33832113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]